-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_executive.pdf
February 01, 2013 - invasive procedures can also lead to additional
invasive tests or treatments that can adversely impact long … three time points: short term (≤30 days after the
procedure), medium term (>30 days to 1 year), and long … With respect to the long-term data (>1 year), three RCTs
found no significant difference in all-cause … outcomes, and few studies reported long-term
outcome data. … Impact of
intravascular ultrasound-guided stenting on long-term
clinical outcome: a meta-analysis of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
September 01, 2011 - of these non-biologic DMARDs, methotrexate, whose
exact mechanism is unknown, has been used for so long … Therefore, trials require
large sample sizes with long followup periods. … Trials that evaluate the
efficacy of treatment should be sufficiently long,
with frequent assessment … Such studies could
also be important for better characterizing long-term
outcomes in JIA. … Because JIA
is a chronic illness, understanding the long-term
adverse effects of these drugs is critical
-
effectivehealthcare.ahrq.gov/sites/default/files/14_substanceabuse_potential_high_impact_june_2012.pdf
January 01, 2012 - Overall High Impact Potential: Long-acting pharmacotherapy for opioid
dependence .................. … Potential for High Impact: Moderately high
Long-Acting Pharmacotherapy for Opioid Dependency … Two long-acting versions of currently used
pharmacotherapies (buprenorphine and naltrexone) have been … Two novel, long-acting
versions of currently used pharmacotherapies (buprenorphine [Probuphine
™
] … Overall High Impact Potential: Long-acting pharmacotherapy for opioid dependence
Overall, experts
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-treatment-future_research.pdf
February 01, 2012 - What are long-term outcomes of mandibular advancement device (MAD)
treatment?
2. … What are long-term outcomes of mandibular advancement devices (MAD) treatment?
2. … What are long-term outcomes of mandibular advancement devices
(MAD) treatment? … since in most cases, treatment can be
expected to be life-long. … However, there is potential for large data loss due to long-term followup.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-228-nonopioid-pharm-chronic-pain-comments.pdf
April 16, 2020 - American
Psychological
Association
Question 3 We also appreciate noting the limited evidence on long … "A long-term RCT
(N=257) found no differences between duloxetine 40 mg/day versus 60
mg/day in pain … Public Reviewer 15
Celeste Cooper
Question 4 RE: Most effects were small; long-term evidence was sparse … As the first report suggests,
“…evidence on long-term treatment effectiveness, comparative effectiveness … In addition, and despite the second report’s finding that “…evidence on long-
term effectiveness [of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-196-evidence-summary-immunotherapy-asthma.pdf
March 01, 2018 - Key Messages
• Subcutaneous immunotherapy
reduces use of long-term control
medications. … Sublingual immunotherapy improves
asthma symptoms, quality of life and
FEV1, and reduces the use of long … Key Points
• SCIT reduces the need for long-term control medication
(moderate strength of evidence [ … • SLIT improves disease-specific quality of life and
decreases use of long-term control medications … SLIT improves asthma symptoms, reduces
long-term control medication use, improves disease-
specific
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-criteria-qdr-protocol.pdf
September 06, 2023 - , the possibility of unforeseen adverse effects on
vulnerable populations, and how best to achieve long-term … order-on-further-advancing-racial-equity-and-support-for-underserved-communities-
through-the-federal-
government/#:~:text=On%20my%20first%20day%20in,long … executive-order-on-further-advancing-racial-equity-and-support-for-underserved-communities-through-the-federal-government/#:%7E:text=On%20my%20first%20day%20in,long … executive-order-on-further-advancing-racial-equity-and-support-for-underserved-communities-through-the-federal-government/#:%7E:text=On%20my%20first%20day%20in,long … executive-order-on-further-advancing-racial-equity-and-support-for-underserved-communities-through-the-federal-government/#:%7E:text=On%20my%20first%20day%20in,long
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd_research-protocol.pdf
August 10, 2010 - Title: Attention Deficit Hyperactivity Disorder:
Effectiveness of Treatment in At-risk Preschoolers; Long … neurodevelopmental
stage when children consolidate social, emotional and cognitive skills that affect long … Long-term effects
Since ADHD is a chronic disorder, many children, teens and adults stay on medications … ADHD in preschoolers and long-term effects of ADHD pharmacotherapy
Alternate text to accompany figure … Studies will be limited for key question two to any publication from 1997 to 2010
because long-term
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
November 01, 2021 - effectiveness of
standard and novel interventions for ADHD, and their potential long-term adverse … Searches will
go back to 1980, when long acting stimulants were introduced, heralding the modern era … Is There Long-Term Benefit From Stimulant Treatment for
ADHD? … Long-Term Effects of Stimulant Treatment for
ADHD: What Can We Tell Our Patients? … Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity
Disorder Effective in the Long
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment-future_research.pdf
February 01, 2013 - fibrinolysis/supportive therapy on intermediate- or long-term clinical
outcomes (nonfatal MI, death, … 5
What is the effectiveness of the following treatment strategies on short-, intermediate- or long- … fibrinolysis/supportive therapy on intermediate- or long-term clinical outcomes (nonfatal MI,
death, … Recommended study design: (preferable) large long-term clinical trial with women-
only enrollment or … With the CABG strategy: Low
(women and men) for long-term (4- to
5-year) composite outcomes
3.
-
effectivehealthcare.ahrq.gov/sites/default/files/14_substance_abuse_potential_high_impact_2012-12-11.pdf
January 01, 2012 - Overall high-impact potential: long-acting pharmacotherapy for opioid
dependence .................. … Potential for High Impact: Moderately high
Long-Acting Pharmacotherapy for Opioid Dependency … Long-acting formulations of these pharmacotherapies
might address these issues. … A novel, long-acting version of currently used pharmacotherapy (buprenorphine
[Probuphine
™
]) has … Overall high-impact potential: long-acting pharmacotherapy for opioid dependence
Overall, experts
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0718-140819.pdf
March 11, 2013 - Staff-Generated PICO
Primary outcome: HAI rates in patients
Population(s): Patients in hospitals or long … Intervention(s): Cleaning, disinfecting, and environmental monitoring of surfaces in
hospital or long … Population(s): Surfaces in hospital or long term care settings, outpatient settings, free
standing surgical
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-executive-summary-2023-update.pdf
January 01, 2023 - versus placebo,2 and two new observational studies,
one of plant-based comparable THC to CBD versus long-acting … new observational study (n=1,310) compared an extracted comparable
THC to CBD ratio product versus long-acting … small short-term
improvements in pain with some cannabis products, but the impact on moderate or long … ),
studies evaluating specific cannabis-based products available in the United States, studies
on long-term … Effectiveness, Safety, and Tolerability of
Nabiximols Oromucosal Spray vs Typical
Oral Long-Acting
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gestational-diabetes-screening-diagnosis_disposition-comments.pdf
January 01, 2020 - Long-term risks are not directly related to short
term outcomes. … We agree that there should be a distinction between
short-term and long-term outcomes. … We have reported
on long-term outcomes among the offspring
although the evidence was very limited. … The studies that met the inclusion criteria did
not report on long-term resource use. … Long-term
Outcomes in Mothers Diagnosed With Gestational Diabetes
Mellitus and Their Offspring.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_executive.pdf
June 01, 2013 - The evidence for both short- and
long-term outcomes was assessed. … Long-Term Outcomes
There are few long-term data on patients with diabetes
or IGT in this weight class … Thus, strength of evidence for long-term adverse
events is rated insufficient. … Thus, we have almost no data
on long-term efficacy and safety. … Again, we found almost no long-term adverse events data
for our target population.
-
effectivehealthcare.ahrq.gov/products/asthma-pharmacologic-treatment/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
February 01, 2012 - Do FGAs and SGAs differ in other short- and long-
term outcomes when used in children, youth, and young … Short-term is defined as outcomes
occurring within 6 months; long-term is defined as
outcomes occurring … Key Question 3: Short- and long-term outcomes. … Summary of the strength of evidence for other short- and long-term
outcomes (Key Question 3)
Outcome … In particular, the
median study duration of 8 weeks is insufficient to
assess some long-term efficacy
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_consumer.pdf
February 01, 2016 - It can be a long-term or
lifelong condition and could come back after treatment. … Alcohol use disorder can be a long-term condition,
like high blood pressure or asthma. … You may need treatment over
a long period of time. … � How long will I need to take the medicine before I know if it is
helping? … � If the medicine helps, how long will I need to keep taking it?
-
effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-apf2_0.xlsx
January 01, 2018 - NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR
Dougados, 1999 Fair AS NSAID Meloxicam 15 mg/d 52 Long … NR NR NR NR NR NR NR NR NR NR NR NR NR NR
Dahlberg, 2009 Fair OA (hip/knee) Celecoxib 200 mg/d 52 Long … NR NR NR NR NR NR NR NR NR NR NR NR NR NR
Dahlberg, 2009 Fair OA (hip/knee) Diclofenac 100 mg/d 52 Long … NR NR NR NR NR NR NR NR NR NR
Nissen, 2016 Fair Mixed Celecoxib 200 to 400 mg/d (mean 209 mg/d) 80 Long … NR NR NR NR NR NR NR NR NR
Nissen, 2016 Fair Mixed Ibuprofen 1800 to 2400 mg/d (mean 2045 mg/d) 80 Long
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-nursing-home-characteristics_research-protocol.pdf
November 03, 2011 - Review Protocol
Project Title: Comparison of Characteristics of Nursing Homes and Other
Residential Long-Term … In 2001, the Institute of
Medicine Committee on Improving the Quality of Long-Term Care specifically … Long-term care for older adults. The role of the family. … Improving the quality of long-term care. Washington, DC:
National Academy Press; 2001.
27. … Office of Disability, Aging, and Long-Term Care Policy.